Ascentage Pharma Group International
OTC:ASPHF
Ascentage Pharma Group International
OTC:ASPHF
Price:
8.48
USD
Market Closed
Market Cap:
$2.7B
Cash Flow Statement
Cash Flow Statement
Ascentage Pharma Group International
Ascentage Pharma Group International
Currency: CNY
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(1 482)
|
0
|
(675)
|
0
|
(832)
|
0
|
(887)
|
0
|
(933)
|
0
|
(395)
|
0
|
|
| Depreciation & Amortization |
26
|
0
|
27
|
0
|
28
|
0
|
61
|
0
|
77
|
0
|
93
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
74
|
0
|
47
|
6
|
29
|
41
|
31
|
21
|
21
|
25
|
|
| Other Non-Cash Items |
984
|
0
|
86
|
0
|
13
|
0
|
67
|
0
|
139
|
0
|
80
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
4
|
4
|
6
|
13
|
17
|
28
|
50
|
85
|
92
|
71
|
61
|
54
|
|
| Change in Working Capital |
11
|
(275)
|
(48)
|
(665)
|
186
|
(586)
|
104
|
(687)
|
(9)
|
(712)
|
111
|
(189)
|
|
| Cash from Operating Activities |
(460)
N/A
|
(542)
-18%
|
(610)
-13%
|
(665)
-9%
|
(605)
+9%
|
(586)
+3%
|
(654)
-12%
|
(687)
-5%
|
(726)
-6%
|
(712)
+2%
|
(111)
+84%
|
(189)
-70%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(81)
|
(193)
|
(251)
|
(335)
|
(437)
|
(367)
|
(237)
|
(127)
|
(57)
|
(39)
|
(24)
|
(28)
|
|
| Other Items |
(120)
|
(178)
|
144
|
(570)
|
(30)
|
763
|
(148)
|
(180)
|
79
|
(6)
|
(338)
|
(907)
|
|
| Cash from Investing Activities |
(201)
N/A
|
(371)
-84%
|
(107)
+71%
|
(905)
-743%
|
(467)
+48%
|
395
N/A
|
(385)
N/A
|
(307)
+20%
|
22
N/A
|
(45)
N/A
|
(362)
-712%
|
(935)
-158%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
432
|
0
|
634
|
1 611
|
1 275
|
298
|
(27)
|
450
|
464
|
520
|
534
|
943
|
|
| Net Issuance of Debt |
42
|
167
|
425
|
363
|
539
|
883
|
696
|
108
|
(13)
|
8
|
(145)
|
(0)
|
|
| Other |
(32)
|
(21)
|
(19)
|
(51)
|
(33)
|
(28)
|
(50)
|
69
|
(82)
|
(218)
|
(74)
|
(74)
|
|
| Cash from Financing Activities |
442
N/A
|
579
+31%
|
1 040
+80%
|
1 923
+85%
|
1 781
-7%
|
1 153
-35%
|
619
-46%
|
627
+1%
|
369
-41%
|
310
-16%
|
315
+2%
|
869
+176%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
1
|
2
|
(42)
|
(45)
|
(23)
|
(8)
|
58
|
66
|
28
|
9
|
14
|
7
|
|
| Net Change in Cash |
(218)
N/A
|
(332)
-52%
|
281
N/A
|
308
+10%
|
687
+123%
|
954
+39%
|
(361)
N/A
|
(301)
+17%
|
(308)
-2%
|
(438)
-42%
|
(145)
+67%
|
(249)
-72%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(542)
N/A
|
(735)
-36%
|
(861)
-17%
|
(1 000)
-16%
|
(1 041)
-4%
|
(954)
+8%
|
(891)
+7%
|
(814)
+9%
|
(783)
+4%
|
(751)
+4%
|
(136)
+82%
|
(217)
-60%
|
|
Switch to:
Switch to:
See Also
Discover More
